In this partner programme, we will explore the different pathways for engagement from both the seller’s and buyer’s perspectives. From pilots to value-added resellers, strategies for point solutions and platforms, and third-party evaluations, there are hundreds of thousands of digital health software products. During this program, we’ll discuss what is working in today’s market, with a focus on U.S. market entry.

3:30PM - 3:50PM
Opening: AI wrote this opening and it is better than the one I wrote myself.

Project Stargate, DeepSeek - everything is AI, even when it isn’t. We’ll open with a quick look at AI’s ever-growing influence in the U.S. digital health market and how to position your digital product to take advantage of this wave before you get left behind.

Speaker:

Ben Vandendriessche, Chief Delivery Officer, DiMe

3:50PM - 4:20PM
Session 1: Why doesn’t anyone in the U.S. reply to my email? Timing & tactics on how U.S. hospital buyers evaluate digital health software

For European digital health software developers aiming to break into the U.S. market, understanding when and how U.S. hospital buyers consider new technology is critical for success. This panel will delve into the key factors that U.S. healthcare decision-makers prioritise when evaluating digital health solutions, the role of pilots in establishing relationships, and when to initiate the conversation around cost. Panelists will share practical insights on the buying cycles, procurement processes, and stakeholder involvement in U.S. hospitals. Additionally, the session will feature success stories from international software developers who have successfully navigated the U.S. healthcare ecosystem, offering lessons learned, strategies for market entry, and real-world examples of what works. Attendees will walk away with actionable advice on timing their market entry and positioning their solutions to meet the needs of U.S. hospital buyers.

Moderator:

Sara Schmachtenberg, Head of Data and Analytics, Europe & USA, Galen Growth

Speakers:

Steve West, Managing Director, Healthiant

Jacob Plummer, CCO, Ada Health

John Dayton, Emergency Medicine Physician, Intermountain Health

Paul Casey, CMO, Rush University System

4:20PM - 4:50PM
Session 2: When someone closes a door, find a window: Innovative approaches to enter the U.S. market

As European digital health software developers look to expand into the U.S. market, developing innovative go-to-market strategies is crucial for success. This panel will focus on creative and effective approaches to entering the U.S. healthcare landscape, emphasising key strategies such as leveraging digital partnerships, aggregation points, and building US-market-centric value propositions. Experts will review companies that have recently demonstrated innovation in their go-to-market strategies, showcasing real-world examples of how they’ve optimised distribution channels, engaged healthcare providers and payers, and successfully driven product adoption. Attendees will learn how to identify compelling value propositions relevant to today’s market, navigate through some of the current complexities of the U.S. healthcare system, and position their products to stand out in a competitive and highly regulated market. 

Moderator:

Ben Vandendriessche, Chief Delivery Officer, DiMe

Speakers:

Ariel Stern, Chair for Digital Health, Economics & Policy, Hasso-Plattner-Institut

Elise King, Managing Director, AHA Ventures

Steve West, Managing Director, Healthiant

Josh Ford, Managing Director, Redesign Health

4:50PM - 5:20PM
Session 3: Whiplash: U.S. healthcare under a new administration and its impact on digital health and AI commercialisation

The U.S. healthcare landscape is undergoing rapid transformation under a new administration, with unprecedented changes reshaping the regulatory environment, funding priorities, and business conditions. For European digital health software developers looking to expand into the U.S. market, understanding these shifts is critical to staying competitive. This panel will explore how the evolving political landscape and broader policy shifts are influencing commercialisation strategies. We’ll discuss what doors may have closed—such as certain reimbursement models or regulatory pathways—and, equally important, which new opportunities are emerging, including new funding sources, partnerships, and business conditions with the international market. Experts will offer insights on how to adjust strategies in response to the administration’s evolving priorities and the changing dynamics of U.S. healthcare. Attendees will leave with a clear understanding of where to focus their efforts and how to capitalise on the new business climate.

Moderator:

Gabby Goldblatt, Associate Director, Healthcare Partnerships, DiMe

Speakers:

Patrick Mahoney, Associate Director Regulatory Affairs, Astellas

Sari Kaganoff, Advisor, Rock Health

Kaveh Safavi, Senior Managing Director, Global Health, Accenture

5:20PM - 5:30PM
Closing remarks
Speaker:

Gabby Goldblatt, Associate Director, Healthcare Partnerships, DiMe

HLTH Partner Programmes are specially curated sessions that bring the biggest healthcare provider leaders and experts together to tackle the biggest system challenges. From governments to associations, providers to physicians, these sessions offer unique insights that tackle the most pressing challenges in healthcare today.